四环生物
(000518)
| 流通市值：31.71亿 | | | 总市值：31.71亿 |
| 流通股本：10.30亿 | | | 总股本：10.30亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 233,853,098.44 | 110,742,539.5 | 81,170,293.95 | 344,383,390.72 |
| 营业总成本 | 285,306,851.39 | 140,621,025.54 | 94,301,571.33 | 377,470,904.68 |
| 其他经营收益 | | | | |
| 营业利润 | -52,078,363.26 | -28,185,569.21 | -12,506,862.98 | -40,524,931.67 |
| 利润总额 | -52,107,178.2 | -28,214,384.15 | -12,506,862.98 | -40,924,440.42 |
| 净利润 | -52,167,836.78 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | 0 | 0 | 0 |
| 综合收益总额 | -52,167,836.78 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 420,132,866.76 | 325,616,392.13 | 325,130,541.55 | 384,705,107.38 |
| 非流动资产: | | | | |
| 非流动资产合计 | 289,771,309.8 | 133,990,990.84 | 154,079,740.58 | 109,337,562.4 |
| 资产总计 | 709,904,176.56 | 459,607,382.97 | 479,210,282.13 | 494,042,669.78 |
| 流动负债: | | | | |
| 流动负债合计 | 288,730,665.89 | 100,422,232.14 | 103,227,516.54 | 106,070,532.99 |
| 非流动负债: | | | | |
| 非流动负债合计 | 90,606,249.28 | 28,263,109.15 | 28,902,825.77 | 28,609,389.27 |
| 负债合计 | 379,336,915.17 | 128,685,341.29 | 132,130,342.31 | 134,679,922.26 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 286,111,035.96 | 308,787,797.89 | 323,307,245.31 | 334,621,015.31 |
| 股东权益合计 | 330,567,261.39 | 330,922,041.68 | 347,079,939.82 | 359,362,747.52 |
| 负债和股东权益合计 | 709,904,176.56 | 459,607,382.97 | 479,210,282.13 | 494,042,669.78 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 120,494,914.86 | 68,618,350.46 | 32,107,834.92 | 305,527,032.73 |
| 经营活动现金流出小计 | 144,679,901.6 | 85,887,694.07 | 47,929,827.24 | 227,409,882.61 |
| 经营活动产生的现金流量净额 | -24,184,986.74 | -17,269,343.61 | -15,821,992.32 | 78,117,150.12 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 457,226.35 | 457,226.35 | 9,257.75 | 1,597,028.64 |
| 投资活动现金流出小计 | 75,678,975.81 | 3,350,140.97 | 1,027,206 | 3,595,542.39 |
| 投资活动产生的现金流量净额 | -75,221,749.46 | -2,892,914.62 | -1,017,948.25 | -1,998,513.75 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 104,800,000 | 10,000,000 | 10,000,000 | 50,000,000 |
| 筹资活动现金流出小计 | 9,630,770.52 | 8,899,044.83 | 8,232,014.43 | 54,386,209.1 |
| 筹资活动产生的现金流量净额 | 95,169,229.48 | 1,100,955.17 | 1,767,985.57 | -4,386,209.1 |
| 汇率变动对现金及现金等价物的影响 | -49,729.72 | -42,734.61 | -28,861.44 | -34,676.79 |
| 现金及现金等价物净增加额 | -4,287,236.44 | -19,104,037.67 | -15,100,816.44 | 71,697,750.48 |
| 期末现金及现金等价物余额 | 75,404,755.13 | 60,587,953.9 | 64,591,175.13 | 79,691,991.57 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -19,104,037.67 | - | 71,697,750.48 |